BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 23030261)

  • 1. Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project.
    Loring DW; Lowenstein DH; Barbaro NM; Fureman BE; Odenkirchen J; Jacobs MP; Austin JK; Dlugos DJ; French JA; Gaillard WD; Hermann BP; Hesdorffer DC; Roper SN; Van Cott AC; Grinnon S; Stout A
    Epilepsia; 2011 Jun; 52(6):1186-91. PubMed ID: 21426327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Coronavirus Standards Working Group's roadmap for improved population testing.
    Mercer T; Almond N; Crone MA; Chain PSG; Deshpande A; Eveleigh D; Freemont P; Fuchs S; Garlick R; Huggett J; Kammel M; Li PE; Milavec M; Marlowe EM; O'Sullivan DM; Page M; Pestano GA; Suliman S; Simen B; Sninsky JJ; Sopchak L; Tato CM; Vallone PM; Vandesompele J; White TJ; Zeichhardt H; Salit M
    Nat Biotechnol; 2022 Nov; 40(11):1563-1568. PubMed ID: 36323792
    [No Abstract]   [Full Text] [Related]  

  • 3. Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy.
    Galanopoulou AS; Mowrey WB
    Epilepsia Open; 2016 Dec; 1(3-4):86-101. PubMed ID: 28497130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCN8A encephalopathy: Research progress and prospects.
    Meisler MH; Helman G; Hammer MF; Fureman BE; Gaillard WD; Goldin AL; Hirose S; Ishii A; Kroner BL; Lossin C; Mefford HC; Parent JM; Patel M; Schreiber J; Stewart R; Whittemore V; Wilcox K; Wagnon JL; Pearl PL; Vanderver A; Scheffer IE
    Epilepsia; 2016 Jul; 57(7):1027-35. PubMed ID: 27270488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a FTO inhibitor with anticonvulsant activity.
    Zheng G; Cox T; Tribbey L; Wang GZ; Iacoban P; Booher ME; Gabriel GJ; Zhou L; Bae N; Rowles J; He C; Olsen MJ
    ACS Chem Neurosci; 2014 Aug; 5(8):658-65. PubMed ID: 24834807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues related to development of new antiseizure treatments.
    Wilcox KS; Dixon-Salazar T; Sills GJ; Ben-Menachem E; White HS; Porter RJ; Dichter MA; Moshé SL; Noebels JL; Privitera MD; Rogawski MA
    Epilepsia; 2013 Aug; 54 Suppl 4(0 4):24-34. PubMed ID: 23909851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy therapy development: technical and methodologic issues in studies with animal models.
    Galanopoulou AS; Kokaia M; Loeb JA; Nehlig A; Pitkänen A; Rogawski MA; Staley KJ; Whittemore VH; Dudek FE
    Epilepsia; 2013 Aug; 54 Suppl 4(0 4):13-23. PubMed ID: 23909850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues for new antiepilepsy drug development.
    Simonato M; French JA; Galanopoulou AS; O'Brien TJ
    Curr Opin Neurol; 2013 Apr; 26(2):195-200. PubMed ID: 23406913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on the working group's 2012 review of the Program.
    Bialer M
    Epilepsia; 2012 Oct; 53(10):1844-6. PubMed ID: 23030267
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiepileptic drug development program.
    Porter RJ
    Prog Clin Biol Res; 1983; 127():53-66. PubMed ID: 6351101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP).
    Kehne JH; Klein BD; Raeissi S; Sharma S
    Neurochem Res; 2017 Jul; 42(7):1894-1903. PubMed ID: 28462454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NIH/NINDS Anticonvulsant Screening Program (ASP): recommendations from the working group's 2012 review of the Program.
    Epilepsia; 2012 Oct; 53(10):1837-9. PubMed ID: 23030261
    [No Abstract]   [Full Text] [Related]  

  • 13. The Anticonvulsant Screening Program of the National Institute of Neurological Disorders and Stroke, NIH: History and Contributions to Clinical Care in the Twentieth Century and Beyond.
    Porter RJ; Kupferberg HJ
    Neurochem Res; 2017 Jul; 42(7):1889-1893. PubMed ID: 28275952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of NINDS to recommendations from the working group's 2012 review of the Program.
    Ranganathan R
    Epilepsia; 2012 Oct; 53(10):1839-40. PubMed ID: 23030262
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.